medline.ch Urologie-Nephrologie
Leaderboard

En | De
Sie sind hier: Urologie-Nephrologie 05. Juni 2023
Suchen
medline.ch
Urologie-Nephrologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Entzündung-Infekt
Nephrolithiasis
Niereninsuffizienz
Sexualität
Tumoren/BPH
Anderes
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 20499  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 409974  
   
Re: Jean-Nicolas Cornu, Paul Zantek, Glyn Burtt, et al. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. Eur Urol. 2023;83:534-47.
Eur Urol
Trujillo CG, Peña Rodríguez S, Diaz Ritter C.
PMID: 37271633 [PubMed - as supplied by publisher]


A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Eur Urol
Colomba E, Jonas SF, Eymard JC, Delva R, Brachet PE, Neuzillet Y, Penel N, Roubaud G, Bompas E, Mahammedi H, Longo R, Helissey C, Barthélemy P, Borchiellini D, Hasbini A, Priou F, Saldana C, Voog E, Narcisso B, Ladoire S, Berdah JF, Aisenfarb JB, Foulon S, Fizazi K.
PMID: 37271630 [PubMed - as supplied by publisher]


Re: Evaluation of Clinical Performance and Safety for the Rechargeable InterStim Micro Device in Overactive Bladder Subjects: 6-month Results from the Global Postmarket ELITE Study.
Eur Urol
De Cillis S, Geretto P, Gallo ML, Phé V.
PMID: 37271629 [PubMed - as supplied by publisher]


The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer.
Korean J Radiol
Cheng L, Yang T, Zhang J, Gao F, Yang L, Tao W.
PMID: 37271211 [PubMed - as supplied by publisher]


Navigating through the haemostatic paradox in kidney failure: A practical overview.
Br J Haematol
Caruana J, Riva N, Vella K, Davenport A, Gatt A.
PMID: 37271168 [PubMed - as supplied by publisher]


Chronic kidney disease and obesity.
Nephron
Hojs R, Ekart R, Bevc S, Vodo.
PMID: 37271131 [PubMed - as supplied by publisher]


Peer support interventions in patients with kidney failure: A systematic review.
J Psychosom Res
Longley RM, Harnedy LE, Ghanime PM, Arroyo-Ariza D, Deary EC, Daskalakis E, Sadang KG, West J, Huffman JC, Celano CM, Amonoo HL.
PMID: 37270909 [PubMed - as supplied by publisher]


Genetic diagnosis of kidney disease by whole exome sequencing and its clinical application.
Clin Genet
Jung J, Lee JH, Seo GH, Keum C, Kang HG, Cho H, Lee H, Park SK, Baek CH, Han R, Lee ST, Cho MH, Yim HE, Koo JW, Lee BH.
PMID: 37270787 [PubMed - as supplied by publisher]


What factors are associated with the prognosis of primary testicular diffuse large B-cell lymphoma? A study based on the SEER database.
J Cancer Res Clin Oncol
Yang S, Chang W, Zhang B, Shang P.
PMID: 37270733 [PubMed - as supplied by publisher]


Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens.
BMC Cancer
Koll FJ, Döring C, Olah C, Szarvas T, Köllermann J, Hoeh B, Chun FK, Reis H, Wild PJ.
PMID: 37270477 [PubMed - in process]


Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial.
Eur Urol
Laukhtina E, Shariat SF.
PMID: 37270391 [PubMed - as supplied by publisher]


Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51.
Eur Urol
Li J, Chen B, Cao D.
PMID: 37270390 [PubMed - as supplied by publisher]


Prognostic Models in Metastatic Renal Cell Carcinoma.
Hematol Oncol Clin North Am
Lemelin A, Takemura K, Heng DYC, Ernst MS.
PMID: 37270385 [PubMed - as supplied by publisher]


Management of Brain Metastases in Metastatic Renal Cell Carcinoma.
Hematol Oncol Clin North Am
Hasanov E, Jonasch E.
PMID: 37270383 [PubMed - as supplied by publisher]


von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.
Hematol Oncol Clin North Am
Shirole NH, Kaelin WG Jr.
PMID: 37270382 [PubMed - as supplied by publisher]


Prospective Validation Study of a Novel Integrated Pathway Based on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for Early Detection of Prostate Cancer.
Eur Urol Oncol
Pecoraro M, Catanzaro G, Conte F, Besharat ZM, Messina E, Laschena L, Trocchianesi S, Splendiani E, Sciarra A, Catalano C, Paci P, Ferretti E, Panebianco V.
PMID: 37270379 [PubMed - as supplied by publisher]


Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Eur Urol Oncol
Gandaglia G, Barletta F, Robesti D, Scuderi S, Rajwa P, Gomez Rivas J, Ibanez L, Soeterik TFW, Bianchi L, Afferi L, Kesch C, Darr C, Guo H, Zhuang J, Zattoni F, Fendler W, Marra G, Stabile A, Amparore D, Huebner NA, Giesen A, Joniau S, Schiavina R, Brunocilla E, Mattei A, Dal Moro F, Sierra JM, Porpiglia F, Picchio M, van den Bergh R, Shariat SF, Montorsi F, Briganti A.
PMID: 37270378 [PubMed - as supplied by publisher]


Prostate-specific antigen level association with COVID-19 infection and vaccination.
Clin Genitourin Cancer
Frumer M, Aharony SM, Shoshany O, Kedar D, Baniel J, Golan S.
PMID: 37270370 [PubMed - as supplied by publisher]


Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
Fizazi K, Herrmann K, Krause BJ, Rahbar K, Chi KN, Morris MJ, Sartor O, Tagawa ST, Kendi AT, Vogelzang N, Calais J, Nagarajah J, Wei XX, Koshkin VS, Beauregard JM, Chang B, Ghouse R, DeSilvio M, Messmann RA, de Bono J.
PMID: 37269841 [PubMed - in process]


Outcomes of Non-ST-Segment Myocardial Infarction During Chronic Heart Failure and End-Stage Renal Disease.
Am J Cardiol
Alhuarrat MAD, Alhuarrat MR, Varrias D, Patel SR, Sims DB, Latib A, Jorde UP, Saeed O.
PMID: 37269688 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 409974    Seite 1 von 20499  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1